S
SentiAR
Digital health company with holographic AR platform for intraprocedural clinical use
About SentiAR
SentiAR, Inc. is a pioneering company in the healthcare technology sector, specializing in the development of a 3D augmented reality platform designed for cardiac interventional procedures. The platform provides real-time holographic visualization of the patient's anatomy, allowing clinicians to interact with the holograms through a headset. This technology converts CT, MRI, and real-time mapping catheter location outputs into a hologram within the clinician's field of view, enhancing the accuracy and speed of procedures. SentiAR primarily serves healthcare providers, particularly those in interventional cardiology, offering a transformative tool that improves both patient and clinician experiences. The company operates in the medical technology market and follows a B2B (business-to-business) model, generating revenue through the sale and licensing of its platform to hospitals and medical institutions. The platform is currently under development for eventual FDA submission, ensuring it meets stringent regulatory standards.
Source: Dealroom company dataAt a glance
- Status
- Operational
- Founded
- 2017
- Headquarters
- St. Louis, United States
- Employees
- 14
- Open positions
- None listed
- Dealroom signal
- 62.2/100
- Industry
- Health
- Sub-industry
- Health Platform
- Sector
- Health Tech & Medtech, Cardiology and cardiovascular, Immersive Technologies, Spinout, DT and LS, science-based
- Technology
- 3D Technology, Deep Tech, Augmented Reality
- Client focus
- b2b
Knowledge graph
More headlines
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| SERIES B✓Equity / VC | Apr 2023 | $8.5M | $34M | Genesis Innovation Group · Harmonix · TechWald Holding · MedVenture Partners | ↗ |
| SERIES A✓Equity / VC | Apr 2021 | $5.1M | $20M | Keiretsu Forum · Cultivation Capital · TechWald Holding · VCapital | — |
Growth signals
Latest recorded traffic for SentiAR is 570 monthly website visits, up 418.2% over the last three months. SentiAR's team declined 12.5% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Seed4 investors entered at this stage
Cultivation Capital
BioGenerator- PHPinpoint Holdings
National Institutes of Health
Series A8 investors entered at this stage
VCapital
Keiretsu Forum
TechWald Holding- QCQRM Capital
Neue Fund
Genesis Innovation Group
Harmonix
MedVenture Partners
Other known investors3 additional known investors
Washington University School Of Medicine
BioGenerator Ventures
Charlie Bolten
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about SentiAR on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See SentiAR’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.